Vascular Diseases  >>  pegylated liposomal doxorubicin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pegylated liposomal doxorubicin / Generic mfg.
NCT00561743: A Study Assessing Safety and Effectiveness of BORTEZOMIB Combination Therapy (Bortezomib + Doxorubicin Hydrochloride + Dexamethasone) in Previously Untreated Multiple Myeloma Patients

Completed
2
50
US
Bortezomib + pegylated liposomal doxorubicin HCl + dexamethasone
Janssen-Ortho Inc., Canada
Multiple Myeloma
05/07
05/07
NCT00148317: Phase II Study of Velcade, Decadron, and Doxil Followed by Cyclophosphamide in Multiple Myeloma

Completed
2
38
US
Bortezomib, velcade, dexamethasone, decadron, liposomal doxorubicin, cyclophoshamide, cytoxan, filgrastim, neupogen
Weill Medical College of Cornell University, Millennium Pharmaceuticals, Inc.
Multiple Myeloma
02/11
11/12
NCT00617591: Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma (MM)

Completed
2
57
US
Lenalidomide, Revlimid®, Pegylated Liposomal Doxorubicin (PLD), Doxil®, Dexamethasone, Decadron®
H. Lee Moffitt Cancer Center and Research Institute, Celgene Corporation, Ortho Biotech Clinical Affairs, L.L.C.
Multiple Myeloma
04/13
04/13
NCT01492881: Study of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma

Withdrawn
2
0
US
Vorinostat, Zolina, Bortezomib, Velcade, pegylated liposomal doxorubicin, Doxil
UNC Lineberger Comprehensive Cancer Center, Merck Sharp & Dohme LLC
Multiple Myeloma
01/15
01/17
NCT00750815: Cyclophosphamide, VELCADE, DOXIL, and Dexamethasone, (CVDD) in Newly Diagnosed Patients With Multiple Myeloma (MM)

Completed
1/2
58
US
Cyclophosphamide, Cytoxan, Bortezomib; Pegylated Liposomal Doxorubicin; Dexamethasone (VDD), VELCADE, DOXIL®, PLD, CVDD, VDD
H. Lee Moffitt Cancer Center and Research Institute, Millennium Pharmaceuticals, Inc., Ortho Biotech, Inc.
Multiple Myeloma
12/12
05/13

Download Options